`U.S. Patent No. 7,064,197
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`
`
`HOLOGIC, INC.,
`Petitioner
`
`
`
`v.
`
`
`
`ENZO LIFE SCIENCES, INC.,
`Patent Owner
`
`__________________
`
`
`
`Case IPR2016-00822
`
`U.S. Patent No. 7,064,197
`TITLE: SYSTEM, ARRAY AND NON-POROUS SOLID SUPPORT
`COMPRISING FIXED OR IMMOBILIZED NUCLEIC ACIDS
`Issue Date: June 20, 2006
`
`__________________
`
`
`
`SECOND UPDATED MANDATORY NOTICES FOR
`PATENT OWNER ENZO LIFE SCIENCES, INC.
`
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`Case IPR2016-00822
`U.S. Patent No. 7,064,197
`
`SECOND UPDATED MANDATORY NOTICES FOR
`PATENT OWNER ENZO LIFE SCIENCES, INC.
`
`Patent Owner Enzo Life Sciences, Inc. hereby files updated mandatory
`
`
`
`notices pursuant to 37 C.F.R. § 42.8.
`
`I.
`
`
`
`REAL PARTY-IN-INTEREST (37 C.F.R. § 42.8(b)(1))
`
`The real party-in-interest for the Patent Owner is Enzo Life Sciences, Inc.
`
`(“Enzo” or “Patent Owner”).
`
`II. RELATED MATTERS (37 C.F.R. § 42.8(b)(2))
`
`A.
`
`Judicial Matters
`
`
`
`The following district court litigations may affect, or be affected by, a
`
`decision in these proceedings: Enzo Life Sciences, Inc. v. Hologic, Inc., Civil
`
`Action No. 1:15-cv-271 (D. Del.); Enzo Life Sciences, Inc. v. Siemens Healthcare
`
`Diagnostics, Inc., Civil Action No. 1:12-cv-505 (D. Del.); Enzo Life Sciences, Inc.
`
`v. Affymetrix, Inc., Civil Action 1:12-cv-433 (D. Del.); Enzo Life Sciences, Inc. v.
`
`Agilent Technologies Inc., Civil Action No. 1:12-cv-434 (D. Del.); Enzo Life
`
`Sciences, Inc. v. Illumina Inc., 1:12-cv-435 (D. Del.); Enzo Life Sciences, Inc. v.
`
`Abbott Laboratories et al., Civil Action No. 1:12-cv-274 (D. Del.); Enzo Life
`
`Sciences, Inc. v. Becton Dickinson and Company et al., Civil Action 1:12-cv-105
`
`(D. Del.); Enzo Life Sciences, Inc. v. Life Technologies Corp., 1:12-cv-105 (D.
`
`Del.); and Enzo Life Sciences, Inc. v. Roche Molecular Systems Inc. et al., Civil
`
`Action No. 1:12-cv-106 (D. Del.).
`
`1
`
`
`
`Case IPR2016-00822
`U.S. Patent No. 7,064,197
`
`B. Administrative Matters
`
`
`
`The following inter partes reviews may affect, or be affected by, a decision
`
`in this proceeding: Case IPR2016-00820, Case IPR2017-00172, and Case
`
`IPR2017-00181, all of which involve U.S. Patent No. 7,064,197.
`
`III. DESIGNATION OF LEAD AND BACK-UP COUNSEL (37 C.F.R.
`§ 42.8(b)(3))
`
`
`
`Patent Owner hereby designates the following lead counsel and back-up
`
`counsel:
`
`1. Kevin K. McNish – Reg. No. 65,047 (Lead Counsel)
`Direct Dial: 212-808-2954
`
`2. Michael P. Stadnick – Pro Hac Vice (Back-up Counsel)
`
`3. Justin P.D. Wilcox – Pro Hac Vice (Back-up Counsel)
`
`4. Kerri-Ann Limbeek – Pro Hac Vice (Back-up Counsel)
`
`
`
`
`
`
`
`
`
`
`Address: DESMARAIS LLP
`
`
`230 Park Avenue
`
`
`New York, NY 10169
`
`
`212-351-3400 (telephone)
`
`
`212-351-3401 (facsimile)
`
`
`EnzoIPRService@desmaraisllp.com
`
`
`kmcnish@desmaraisllp.com
`
`
`mstadnick@desmaraisllp.com
`jwilcox@desmaraisllp.com
`klimbeek@desmaraisllp.com
`
`
`IV. SERVICE INFORMATION (37 C.F.R. § 42.8(b)(4))
`
`
`
`Please direct all correspondence regarding this proceeding to Lead Counsel
`
`at the address listed above. Patent Owner also consents to electronic service by
`
`2
`
`
`
`Case IPR2016-00822
`U.S. Patent No. 7,064,197
`
`
`to EnzoIPRService@desmaraisllp.com,
`
`kmcnish@desmaraisllp.com,
`
`mstadnick@desmaraisllp.com,
`
`jwilcox@desmaraisllp.com,
`
`and
`
`klimbeek@desmaraisllp.com.
`
`Dated: January 13, 2017
`
`
`
`
`
`Respectfully submitted,
`
`/kkm/
`Kevin K. McNish (Reg. No. 65,047)
`kmcnish@desmaraisllp.com
`DESMARAIS LLP
`230 Park Avenue
`New York, NY 10169
`Telephone: 212-351-3400
`Facsimile: 212-351-3401
`
`Lead Counsel for Patent Owner
`Enzo Life Sciences, Inc.
`
`
`
`
`
`3
`
`
`
`Case IPR2016-00822
`U.S. Patent No. 7,064,197
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned certifies that on January 13,
`
`2017, a complete copy of the foregoing was served on counsel of record for the
`Petitioner by filing this document through PTAB E2E and by sending this
`document via electronic mail to the following addresses:
`
`M. Paul Barker (Reg. No. 32,013)
`Finnegan, Henderson, Farabow, Garrett &
`Dunner, L.L.P.
`Stanford Research Park
`3300 Hillview Avenue
`Palo Alto, CA 94304-1203
`Telephone: 650.849.6620
`Facsimile: 650.849.6666
`paul.barker@finnegan.com
`
`Thomas L. Irving (Reg. No. 28,619)
`Finnegan, Henderson, Farabow,
`Garrett & Dunner, L.L.P.
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Telephone: 202.408.4082
`Facsimile: 202.408.4400
`tom.irving@finnegan.com
`
`Arpita Bhattacharyya
`63,681)
`Finnegan, Henderson,
`Garrett & Dunner, L.L.P.
`Two Seaport Lane, 6th Floor
`Boston, MA 02210-2001
`Telephone: 617.646.1675
`Facsimile: 617.646.1600
`arpita.bhattacharyya@finnegan.com
`
`Respectfully submitted,
`
`(Reg. No.
`
`Farabow,
`
`Dated: January 13, 2017
`
`
`
`4
`
`/kkm/
`Kevin K. McNish (Reg. No. 65,047)
`kmcnish@desmaraisllp.com
`DESMARAIS LLP
`230 Park Avenue
`New York, NY 10169
`Telephone: 212-351-3400
`Facsimile: 212-351-3401
`
`Lead Counsel for Patent Owner Enzo
`Life Sciences, Inc.